Spero Therapeutics updates investor presentation; no material new financial or operational data disclosed

Spero Therapeutics, Inc.

Filed an updated investor presentation dated September 9, 2024, under Regulation FD.
Presentation available on Spero's IR website; company disclaims obligation to update after that date.
No specific financial metrics, pipeline updates, or guidance changes were provided in the filing.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.